Select Medical
SEM was delisted on the 30th of June, 2026.
208 hedge funds and large institutions have $1.62B invested in Select Medical in 2018 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 80 increasing their positions, 61 reducing their positions, and 27 closing their positions.
1,730% more call options, than puts
Call options by funds: $16.6M | Put options by funds: $909K
44% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 27
31% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 61
6% more funds holding
Funds holding: 197 → 208 (+11)
1.64% more ownership
Funds ownership: 143.12% → 144.75% (+1.6%)
16% less capital invested
Capital invested by funds: $1.92B → $1.62B (-$301M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$24.6M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$17.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.7M |
| 4 |
D.E. Shaw & Co
New York
|
+$8.17M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$7.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
-$19.1M |
| 2 |
O
OrbiMed
New York
|
-$19M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.3M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$15.7M |
| 5 |
RI
Redwood Investments
Boston,
Massachusetts
|
-$13.2M |
SEM Hedge Fund Activity: Q4 2018 in Review
208 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q4 2018, worth a combined $1.62B — down 16% from $1.92B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new SEM positions and 27 closed out — a net gain of 12 holders — while 80 added to existing stakes and 61 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $24.6M. The largest seller was Fisher Asset Management, cutting an estimated $19.1M.
- 208 institutional investors held Select Medical (SEM) as of Q4 2018, up from 197 in Q3 2018.
- Funds reported $1.62B of Select Medical stock for Q4 2018, down 16% quarter-over-quarter.
- 39 funds opened new Select Medical positions in Q4 2018 and 27 closed out, a net change of +12 holders.
- The largest Select Medical buyer in Q4 2018 was T. Rowe Price Associates, an estimated $24.6M added.
- The largest Select Medical seller in Q4 2018 was Fisher Asset Management, an estimated $19.1M sold.
Based on aggregated 13F filings for Q4 2018.